Growth-restricted preterm newborns are predisposed to functional adrenal hyperandrogenism in adult life

European Journal of Endocrinology

Volumn 163, Issue 4, 2010, Pages 681-689

  Meuwese, Christiaan L ^a   Euser, Anne M ^a   Ballieux, Bart E ^a   Van Vliet, Huib A ^a   Finken, Martijn J J ^a,b   Walther, Frans J ^a   Dekker, Friedo W ^a   Wit, Jan M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; BETAMETHASONE; DEXAMETHASONE; HYDROCORTISONE; LEVOTHYROXINE; PRASTERONE SULFATE; INSULIN; ORAL CONTRACEPTIVE AGENT;

ADRENAL DISEASE; ADULT; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GROWTH RETARDATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERANDROGENISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POSTNATAL CARE; POSTNATAL GROWTH; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SMALL FOR DATE INFANT; WEIGHT GAIN; ADOLESCENT; ADRENAL GLAND DISEASES; BLOOD; GESTATIONAL AGE; IMMUNOASSAY; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; REGRESSION ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADRENAL GLAND DISEASES; ADULT; ANDROSTENEDIONE; BIRTH WEIGHT; CONTRACEPTIVES, ORAL; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; HYDROCORTISONE; HYPERANDROGENISM; IMMUNOASSAY; INFANT, NEWBORN; INSULIN; INSULIN RESISTANCE; MALE; PREGNANCY; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 77957155106     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0471     Document Type: Article

References (46)

1. Barker DJ. The developmental origins of adult disease. Journal of the American College of Nutrition 2004 23 588S-595S.
2. Finken MJ, Keijzer-Veen MG, Dekker FW, Frolich M, Hille ET, Romijn JA & Wit JM. Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life. Diabetologia 2006 49 478-485. (doi:10.1007/s00125-005-0118-y)
3. van Montfoort N, Finken MJ, le Cessie S, Dekker FW & Wit JM. Could cortisol explain the association between birth weight and cardiovascular disease in later life? A meta-analysis. European Journal of Endocrinology 2005 153 811-817. (doi:10.1530/eje.1.02050) (Pubitemid 43020231)
4. Dahlgren J, Boguszewski M, Rosberg S & Bertsson-Wikland K. Adrenal steroid hormones in short children born small for gestational age. Clinical Endocrinology 1998 49 353-361. (doi:10.1046/j.1365-2265.1998.00514.x)
5. Francois I & de Zegher F. Adrenarche and fetal growth. Pediatric Research 1997 41 440-442. (doi:10.1203/00006450-199703000-00023)
6. Radetti G, Renzullo L, Gottardi E, D'Addato G & Messner H. Altered thyroid and adrenal function in children born at term and preterm, small for gestational age. Journal of Clinical Endocrinology and Metabolism 2004 89 6320-6324. (doi:10.1210/jc.2003-032185) (Pubitemid 39628453)
7. Szathmari M, Vasarhelyi B & Tulassay T. Effect of low birth weight on adrenal steroids and carbohydrate metabolism in early adulthood. Hormone Research 2001 55 172-178. (doi:10.1159/000049991)
8. Jaquet D, Leger J, Chevenne D, Czernichow P & Levy-Marchal C. Intrauterine growth retardation predisposes to insulin resistance but not to hyperandrogenism in young women. Journal of Clinical Endocrinology and Metabolism 1999 84 3945-3949. (doi:10.1210/jc.84.11.3945)
9. Boonstra VH, Mulder PG, de Jong FH & Hokken-Koelega AC. Serum dehydroepiandrosterone sulfate levels and pubarche in short children born small for gestational age before and during growth hormone treatment. Journal of Clinical Endocrinology and Metabolism 2004 89 712-717. (doi:10.1210/jc.2003- 031160)
10. Ibanez L, Potau N, Marcos MV & de Zegher F. Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. Journal of Clinical Endocrinology and Metabolism 1999 84 4739-4741. (doi:10.1210/jc.84. 12.4739)
11. Ibanez L, Potau N, Marcos MV & de Zegher F. Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche. Clinical Endocrinology 2000 53 523-527. (doi:10.1046/j.1365-2265.2000.01133.x)
12. Ong KK, Potau N, Petry CJ, Jones R, Ness AR, Honour JW, de Zegher F, Ibanez L & Dunger DB. Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. Journal of Clinical Endocrinology and Metabolism 2004 89 2647-2651. (doi:10.1210/jc.2003-031848)
13. Crowther CA & Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database of Systematic Reviews, 2007. CD003935. (doi:10.1002/14651858. CD003935.pub2)
14. Halliday HL, Ehrenkranz RA & Doyle LW. Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews, 2010. CD001146. (doi:10.1002/14651858.CD001146. pub3)
15. Levitt NS, Lindsay RS, Holmes MC & Seckl JR. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 1996 64 412-418. (doi:10.1159/000127146)
16. Ng PC, Wong GW, Lam CW, Lee CH, Wong MY, Fok TF, Wong W & Chan DC. Pituitary-adrenal response in preterm very low birth weight infants after treatment with antenatal corticosteroids. Journal of Clinical Endocrinology and Metabolism 1997 82 3548-3552. (doi:10.1210/jc.82.11.3548)
17. Ng PC, Wong GW, Lam CW, Lee CH, Fok TF, Wong MY & Ma KC. Effect of multiple courses of antenatal corticosteroids on pituitary-adrenal function in preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 1999 80 F213-F216. (doi:10.1136/fn.80.3.F213)
18. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A & Harding JE. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 2005 365 1856-1862. (doi:10.1016/S0140-6736(05)66617-2) (Pubitemid 40744963)
19. Wit JM, Finken MJ, Rijken M & de Zegher F. Preterm growth restraint: a paradigm that unifies intrauterine growth retardation and preterm extrauterine growth retardation and has implications for the small-for-gestational-age indication in growth hormone therapy. Pediatrics 2006 117 e793-e795. (doi:10.1542/peds.2005-1705)
20. Euser AM, Finken MJ, Keijzer-Veen MG, Hille ET, Wit JM & Dekker FW. Associations between prenatal and infancy weight gain and BMI, fat mass, and fat distribution in young adulthood: a prospective cohort study in males and females born very preterm. American Journal of Clinical Nutrition 2005 81 480-487.
21. Hille ET, Weisglas-Kuperus N, van Goudoever JB, Jacobusse GW, Ens-Dokkum MH, de Groot L, Wit JM, Geven WB, Kok JH, de Kleine MJ, Kolle LA, Mulder AL, van Straaten HL, de Vries LS, van Weissenbruch MM, Verloove-Vanhorick SP & Dutch Collaborative POPS 19 Study Group . Functional outcomes and participation in young adulthood for very preterm and very low birth weight infants: the Dutch Project on Preterm and Small for gestational age infants at 19 years of age. Pediatrics 2007 120 e587-e595. (doi:10.1542/peds.2006-2407)
22. Hille ET, Elbertse L, Gravenhorst JB, Brand R & Verloove-Vanhorick SP. Nonresponse bias in a follow-up study of 19-yearold adolescents born as preterm infants. Pediatrics 2005 116 e662-e666. (doi:10.1542/peds.2005-0682) (Pubitemid 46056397)
23. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C & Karlberg P. An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977-1981). Acta Paediatrica Scandinavica 1991 80 756-762. (doi:10.1111/j.1651-2227.1991.tb11945.x)
24. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP & Wit JM. Continuing positive secular growth change in The Netherlands 1955-1997. Pediatric Research 2000 47 316-323. (doi:10.1203/00006450-200003000-00006)
25. Fredriks AM, van Buuren S, Fekkes M, Verloove-Vanhorick SP & Wit JM. Are age references for waist circumference, hip circumference and waist-hip ratio in Dutch children useful in clinical practice? European Journal of Pediatrics 2005 164 216-222. (doi:10.1007/s00431-004-1586-7)
26. Keirse MJ. Obstetrical attitudes to glucocorticoid treatment for fetal lung maturation: time for a change? European Journal of Obstetrics, Gynecology, and Reproductive Biology 1984 17 247-255. (doi:10.1016/0028-2243(84)90067-4)
27. Li L, Power C, Kelly S, Kirschbaum C & Hertzman C. Lifetime socio-economic position and cortisol patterns in mid-life. Psychoneuroendocrinology 2007 32 824-833. (doi:10.1016/j.psyneuen.2007.05.014) (Pubitemid 47189731)
28. Eskola V, Lenko HL & Tammela O. Impaired adrenocortical function in very low birth weight infants after multiple pregnancies. European Journal of Endocrinology 2003 149 529-534. (doi:10.1530/eje.0.1490529) (Pubitemid 38054696)
29. Hernandez MI, Martinez A, Capurro T, Pena V, Trejo L, Avila A, Salazar T, Asenjo S, Iniguez G & Mericq V. Comparison of clinical, ultrasonographic, and biochemical differences at the beginning of puberty in healthy girls born either small for gestational age or appropriate for gestational age: preliminary results. Journal of Clinical Endocrinology and Metabolism 2006 91 3377-3381. (doi:10.1210/jc.2005-2368)
30. Tenhola S, Martikainen A, Rahiala E, Parviainen M, Halonen P & Voutilainen R. Increased adrenocortical and adrenomedullary hormonal activity in 12-year-old children born small for gestational age. Journal of Pediatrics 2002 141 477-482. (doi:10.1067/mpd.2002.126923) (Pubitemid 35193311)
31. Ibanez L, Valls C, Potau N, Marcos MV & de Zegher F. Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect. Clinical Endocrinology 2001 55 667-672. (doi:10.1046/j.1365-2265.2001.01399.x)
32. Wilson DM, Baldwin RB & Ariagno RL. A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants. Journal of Pediatrics 1988 113 764-768. (doi:10.1016/S0022- 3476(88)80398-6)
33. Moghetti P, Castello R, Negri C, Tosi F, Spiazzi GG, Brun E, Balducci R, Toscano V & Muggeo M. Insulin infusion amplifies 17 alpha- hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. Journal of Clinical Endocrinology and Metabolism 1996 81 881-886. (doi:10.1210/jc.81.3.881)
34. Fernandez-Real JM, Grasa M, Casamitjana R & Ricart W. The insulin resistance syndrome and the binding capacity of cortisol binding globulin (CBG) in men and women. Clinical Endocrinology 2000 52 93-99. (doi:10.1046/j.1365- 2265.2000.00864.x) (Pubitemid 30108290)
35. Nelson DH. The adrenal cortex: physiological function and disease. Major Problems in Internal Medicine 1980 18 1-281.
36. Dunn JF, Nisula BC & Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. Journal of Clinical Endocrinology and Metabolism 1981 53 58-68. (doi:10.1210/jcem-53-1-58)
37. Dunaif A, Mandeli J, Fluhr H & Dobrjansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1988 66 131-139. (doi:10.1210/jcem-66-1-131)
38. Conway GS, Jacobs HS, Holly JM & Wass JA. Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome. Clinical Endocrinology 1990 33 593-603. (doi:10.1111/j.1365-2265.1990.tb03897.x)
39. Wiegratz I, Kutschera E, Lee JH, Moore C, Mellinger U, Winkler UH & Kuhl H. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception 2003 67 25-32. (doi:10.1016/S0010- 7824(02)00436-5) (Pubitemid 36084284)
40. Aden U, Jung-Hoffmann C & Kuhl H. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. Contraception 1998 58 75-81. (doi:10.1016/S0010-7824(98)00071-7)
41. Zumoff BV & Bradlow HL. Sex difference in the metabolism of dehydroisoandrosterone sulfate. Journal of Clinical Endocrinology and Metabolism 1980 51 334-336. (doi:10.1210/jcem-51-2-334)
42. Young DG, Skibinski G, Mason JI & James K. The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor beta 1 (TGF-beta1) levels in normal healthy blood donors. Clinical and Experimental Immunology 1999 117 476-481. (doi:10.1046/j.1365-2249.1999.01003.x)
43. Coenen CM, Thomas CM, Borm GF, Hollanders JM & Rolland R. Changes in androgens during treatment with four low-dose contraceptives. Contraception 1996 53 171-176. (doi:10.1016/0010-7824(96)00006-6) (Pubitemid 26082289)
44. Moutos D, Smith S & Zacur H. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial. Contraception 1995 52 105-109. (doi:10.1016/S0010-7824(95)00137-9)
45. Handa RJ, Burgess LH, Kerr JE & O'Keefe JA. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Hormones and Behavior 1994 28 464-476. (doi:10.1006/hbeh.1994.1044)
46. Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet 2004 363 1728-1731. (doi:10.1016/S0140-6736(04)16261- 2)